Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at BIO-Europe Spring|March 18–20, 2024|Booth #34

Recombinant Sudan ebolavirus GP, His-tagged

Cat.No. : GP-18S
Product Overview : A DNA sequence encoding Sudan ebolavirus (strain Gulu) GP (Met1-Asn637) was expressed with a polyhistidine tag at the C-terminus.
  • Specification
  • Gene Information
  • Related Products
Description : The fourth gene of the EBOV genome encodes a 160-kDa envelope-attached glycoprotein (GP) and a 110 kDa secreted glycoprotein (sGP). Both GP and sGP have an identical 295-residue N-terminus, however, they have different C-terminal sequences. Recently, great attention has been paid to GP for vaccines design and entry inhibitors isolation. GP is a class I fusion protein which assembles as trimers on viral surface and plays an important role in virus entry and attachment. Mature GP is a disulfide-linked heterodimer formed by two subunits, GP1 and GP2, which are generated from the proteolytical process of GP precursor (pre-GP) by cellular furin during virus assembly . The GP1 subunit contains a mucin domain and a receptor-binding domain (RBD); the GP2 subunit has a fusion peptide, a helical heptad-repeat (HR) region, a transmembrane (TM) domain, and a 4-residue cytoplasmic tail. The RBD of GP1 mediates the interaction of EBOV with cellular receptor (e.g. DC-SIGN/LSIGN, TIM-1, hMGL, NPC1, β-integrins, folate receptor-α, and Tyro3 family receptors), of which TIM1 and NPC1 are essential for EBOV entry; the mucin domain having N- and O-linked glycans enhances the viral attachment to cellular hMGL, and participates in shielding key neutralization epitopes, which helps the virus evades immune elimination. There are large conformation changes of GP2 during membrane fusion, which enhance the insertion of fusion loop into cellular membrane and facilitate the release of viral nucleocapsid core to cytoplasm.
Source : Human Cells
Species : Sudan ebolavirus
Tag : His
Predicted N Terminal : Met 33
Form : Lyophilized from sterile PBS, pH 7.4.
Molecular Mass : The recombinant Sudan ebolavirus (strain Gulu) GP consists 616 amino acids and predicts a molecular mass of 67.9 kDa.
Endotoxin : <1.0 eu per μg protein as determined by the lal</1.0
Purity : >(51.8+27.5+16.9)% as determined by SDS-PAGE.
Stability : Samples are stable for up to twelve months from date of receipt at -70oC.
Storage : Store it under sterile conditions at -20oC to -80oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution : A hardcopy of COA with reconstitution instruction is sent along with the products.?
Shipping : In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Gene Name : GP small secreted glycoprotein [ Sudan ebolavirus ]
Official Symbol : GP
Synonyms : GP; EBOV-G; Glycoprotein; virion spike glycoprotein precursor; small secreted glycoprotein; spike glycoprotein; YP_138523.1; processed by furin to yield GP1-GP2 heterodimer that forms membrane-anchored trimers (peplomers); YP_138524.1; forms dimers linked by disulfide bonds (parallel orientation); processed by furin to yield SGP and delta peptide
Gene ID : 3160774
Protein Refseq : YP_138523

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (0)

Ask a question

Customer Reviews (0)

Write a review

Ask a Question for All GP Products

Required fields are marked with *

My Review for All GP Products

Required fields are marked with *

0

Inquiry Basket

cartIcon
logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends